NCT05011006View on ClinicalTrials.gov

NT-3 Levels and Function in Individuals With CMT

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 13, 2027

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
Charcot-Marie-Tooth DiseasePeripheral NeuropathyChronic Inflammatory Demyelinating Polyneuropathy
Interventions
DIAGNOSTIC_TEST

NT3 blood draw

blood draw

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
lead

Zarife Sahenk

OTHER